CHK2 immunohistochemical expression in colon cancer and its relation with clinicopathological features and outcome in metastatic colon cancer patients (2014)
- Authors:
- USP affiliated authors: SILVA, ALFREDO RIBEIRO DA - FMRP ; GARCIA, SERGIO BRITTO - FMRP ; FERES, OMAR - FMRP ; ROCHA, JOSE JOAQUIM RIBEIRO DA - FMRP ; PERIA, FERNANDA MARIS - FMRP
- Unidade: FMRP
- DOI: 10.4172/2157-7099.1000288
- Subjects: NEOPLASIAS DO COLON; EXPRESSÃO GÊNICA; DANO AO DNA
- Language: Inglês
- Imprenta:
- Publisher place: Los Angeles
- Date published: 2014
- Source:
- Título: Journal of Cytology and Histology
- ISSN: 2157-7099
- Volume/Número/Paginação/Ano: v. 5, n. 6, art. 288, 2014
- Status:
- Artigo possui acesso gratuito no site do editor (Bronze Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
RIBEIRO, Karen Bento et al. CHK2 immunohistochemical expression in colon cancer and its relation with clinicopathological features and outcome in metastatic colon cancer patients. Journal of Cytology and Histology, v. 5, n. 6, 2014Tradução . . Disponível em: https://doi.org/10.4172/2157-7099.1000288. Acesso em: 02 abr. 2026. -
APA
Ribeiro, K. B., Zanetti, J. da S., Silva, A. R. da, Pansani, F., Garcia, S. B., Feres, O., et al. (2014). CHK2 immunohistochemical expression in colon cancer and its relation with clinicopathological features and outcome in metastatic colon cancer patients. Journal of Cytology and Histology, 5( 6). doi:10.4172/2157-7099.1000288 -
NLM
Ribeiro KB, Zanetti J da S, Silva AR da, Pansani F, Garcia SB, Feres O, Rocha JJR da, Peria FM. CHK2 immunohistochemical expression in colon cancer and its relation with clinicopathological features and outcome in metastatic colon cancer patients [Internet]. Journal of Cytology and Histology. 2014 ; 5( 6):[citado 2026 abr. 02 ] Available from: https://doi.org/10.4172/2157-7099.1000288 -
Vancouver
Ribeiro KB, Zanetti J da S, Silva AR da, Pansani F, Garcia SB, Feres O, Rocha JJR da, Peria FM. CHK2 immunohistochemical expression in colon cancer and its relation with clinicopathological features and outcome in metastatic colon cancer patients [Internet]. Journal of Cytology and Histology. 2014 ; 5( 6):[citado 2026 abr. 02 ] Available from: https://doi.org/10.4172/2157-7099.1000288 - CHK2 expression as predictor factor of tumor aggressiveness and shorter survival in metastatic colon cancer patients
- Hyperbaric oxygen therapy reduces COX-2 expression in a dimethylhydrazine-induced rat model of colorectal carcinogenesis
- Effect of hyperbaric oxygen therapy on the intestinal ischemia reperfusion injury
- KRAS mutation associated with CD44/CD166 immuoexpression as predictors of worse outcome in metastic colon cancer
- Clinical-pathological correlation of KRAS mutation status in metastatic colorectal adenocarcinoma
- Analysis of gene expression EGFR and KRAS, microRNA-21 and microRNA-203 in patients with colon and rectal cancer and correlation with clinical outcome and prognostic factors
- Serological under expression of microRNA-21, microRNA-34a and microRNA-126 in colorectal cancer
- Transanal endoscopic operation for rectal cancer after neoadjuvant therapy
- Comparative evaluation of oncologic outcomes in colon cancer
- Tumores colorretais síncronos em doença de Cröhn: relato de caso
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
